Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2005-12-06
2005-12-06
Vogel, Nancy (Department: 1636)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S029000
Reexamination Certificate
active
06972175
ABSTRACT:
This invention provides methods for determining whether an agent increases PPAR-γ-mediated inhibition of Egr-1 expression. This invention also provides methods for inhibiting the onset of atherosclerosis in a transplanted organ. This invention further provides numerous methods for treating disorders, and/or inhibiting the onset of disorders or disorder-related complications by using PPAR-γ agonists. This invention still further provides related methods for inhibiting cancer metastasis, treating and inhibiting the onset of a heart attack, and treating burn and crush injuries. Finally, this invention provides related articles of manufacture.
REFERENCES:
patent: 6486142 (2002-11-01), Leblance et al.
Adams, D.H., and Lloyd, A.R. (1997) Chemokines: leucocyte recruitment and activation cytokines. Lancet 349:490-495 (Exhibit 1).
Brun, R.P., Tontonoz, P., Forman, B.M., Ellis, R., Chen, J., Evans, R.M., and Spiegelman, B.M. (1996) Differential activation of adipogenesis by multiple PPAR isoforms. Genes. Dev. 10:974-984 (Exhibit 2).
Forman, B.M., Tontonoz, P., Chen, J., Brun, R.P., Spiegelman, B.M., and Evans, R.M. (1995) 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83:803-812 (Exhibit 3).
Furie, M.B., and Randolph, G.J. (1995) Chemokines and tissue injury, Am. J. Pathol. 146:1287-1301 (Exhibit 4).
Gashler, A., and Sukhatme, V. P. (1995) Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog. Nucleic. Acid. Res. Mol. Biol. 50:191-224 (Exhibit 5).
Goldblum, S.E., Wu, K.M., and Jay, M. (1985) Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J. Appl. Physiol. 59:1978-1985 (Exhibit 6).
Heemann, U., Szabo, A., Hamar, P., Muller, V., Witzke, O., Lutz, J., and Philipp, T. (2000) Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury: possible connection to an interleukin-6-dependent pathway. Am. J. Pathol. 156:287-293 (Exhibit 7).
Herskowitz, A., Choi, S., Ansari, A.A., and Wesselingh, S. (1995) Cytokine mRNA expression in postischemic/reperfused myocardium. Am. J. Pathol. 146:419-428 (Exhibit 8).
Jiang, C., Ting, A.T., and Seed, B. (1998) PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-6 (Exhibit 9).
Lehmann, J.M., Moore, L.B., Smith-Oliver, T.A., Wilkison, W.O., Willson, T.M., and Kliewer, S.A. (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270:12953-12956 (Exhibit 10).
Miura, M., Fu, X., Zhang, Q.W., Remick, D.G., and Fairchild, R.L. (2001) Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury. Am. J. Pathol. 159:2137-2145 (Exhibit 11).
Nakajima, A., Wada, K., Miki, H., Kubota, N., Nakajima, N., Terauchi, Y., Ohnishi, S., Saubermann, L.J., Kadowaki, T., Blumberg, R.S., Nagai, R., and Matsuhashi, N. (2001) Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology 120:460-469 (Exhibit 12).
Nguyen, H.Q., Hoffman-Liebermann, B., and Liebermann, D.A. (1993) The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage. Cell 72:197-209 (Exhibit 13).
Okada, M., Fujita, T., Sakaguchi, T., Olson, K.E., Collins, T., Stern, D.M., Yan, S.F., and Pinsky, D.J. (2001) Extinguishing Egr-1-dependent inflammatory and thrombotic cascades after lung transplantation. FASEB. J. 15:2757-2759 (Exhibit 14).
Ricote, M.F., Li, A.C., Willson, T.M., Kelly, C.J., and Glass, C.K. (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391:79-82 (Exhibit 15).
Ricote, M., Huang, J.T., Welch, J.S., and Glass, C.K. (1999) The peroxisome proliferator-activated receptor (PPAR-gamma) as a regulator of monocyte/macrophage function. J. Leukoc. Biol. 66:733-739 (Exhibit 16).
Schoonjans, K., Martin, G., Staels, B., Auwerx, J. (1997) Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr. Opin. Lipidol. 8:159-166 (Exhibit 17).
Venditti, P., Masullo, P., Di Meo, S., and Agnisola, C. (1999) Protection against ischemia-reperfusion induced oxidative stress by vitamin E treatment. Arch. Physiol. Biochem. 107:27-34 (Exhibit 18).
Venditti, P., Masullo, P., Agnisola, C., and Di Meo, S. (2000) Effect of vitamin E on the response to ischemia-reperfusion of Langendorff heart preparations from hyperthyroid rats. Life Sci. 66:697-708 (Exhibit 19).
Yan, S.F., Tritto, I., Pinsky, D., Liao, H., Huang, J., Fuller, G.F., Brett, J., May, L., and Stern, D. (1995) Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J. Biol. Chem. 270:11463-11471 (Exhibit 20).
Yan, S.F., Lu, J., Zou, Y.S., Soh-Won, J., Cohen, D. M., Buttrick, P.M., Cooper, D.R., Steinberg, S.F., Mackman, N., Pinsky, D.J., and Stern, D.M. (1999) Hypoxia-associated induction of early growth response-1 gene expression. J. Biol. Chem. 274:15030-15040 (Exhibit 21).
Yan, S.F., Fujita, T., Lu, J., Okada, K., Shan Zou, Y., Mackman, N., Pinsky, D.J., and Stern, D.M. (2000) Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nature Medicine 6:1355-1361 (Exhibit 22).
Jiang, Chengyu et al., “PPAR-γ agonists inhibit production of monocyte inflammatory cytokines”, Nature, vol. 391, (1998), pp. 82-86.
Nguyen, Hung Q, et al., “The Zinc Finger Transcription Factor Egr-1 Is Essential for and Restricts Differentiation along the Macrophage Lineage”, Cell, vol. 72, (1993), pp. 197-209.
Ricote, Mercedes, et al., “The peroxisome proliferators-activated receptorγ (PPARγ) as a regulator of monocyte/macrophage function”, Journal of Leukocyte Biology, vol. 66, (1999), pp. 733-739.
Schoonjans, Kristina, et al., “Peroxisome proliferators-activated receptors, orphans with ligands and fuctions”, Current Opinion in Lipidology vol. 8, (1997), pp. 159-166.
Mar. 4, 2005 Written Opinion Of The International Searching Authority in connection with International Application No. PCT/US03/37823.
Mar. 4, 2005 International Search Report in connection with PCT/US03/37823.
Collins Tucker
Pinsky David
Cooper & Dunham LLP
Vogel Nancy
White, Esq. John P.
LandOfFree
Inhibition of Egr-1 expression by ppar-gamma agonists and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of Egr-1 expression by ppar-gamma agonists and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of Egr-1 expression by ppar-gamma agonists and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3506939